Brief: Sensus Healthcare's Srt Treatment Shows Promise In Treating Cutaneous Mast Cell Tumors Among Pet Patients
17/05/2023 13:07
Sensus Healthcare Inc SRTS.O :
* SENSUS HEALTHCARE'S SRT TREATMENT SHOWS PROMISE IN
TREATING
CUTANEOUS MAST CELL TUMORS AMONG PET PATIENTS
Source text for Eikon: ID:nGNX2fF6wV
Further company coverage: SRTS.O
Recent news on Sensus Healthcare
See all newsSensus Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Sensus Healthcare Q2 revenue misses estimates as unit sales fall
Brief: Sensus Healthcare Q2 Net Income USD -8.749 Million
Sensus Healthcare Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Sensus Healthcare - Enters $15 Million Revolving Credit Facility With City National Bank Of Florida - SEC Filing